| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.05. | Sagimet Biosciences Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 16.05. | Sagimet Biosciences Inc.: Sagimet Biosciences to Host Virtual Investor and Analyst Day on Inhibiting Fatty Acid Synthase (FASN) to Reduce Liver Fat, Inflammation and Fibrosis in MASH on May 23, 2024 | 5 | GlobeNewswire (USA) | ||
| 15.05. | Sagimet Biosciences Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.05. | Sagimet Biosciences Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 06.05. | Sagimet Biosciences Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 06.05. | Sagimet Biosciences Inc.: Sagimet Biosciences Announces Appointment of Thierry Chauche as Chief Financial Officer | 192 | GlobeNewswire (Europe) | SAN MATEO, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors... ► Artikel lesen | |
| 27.03. | Sagimet Biosciences Inc.: Sagimet Biosciences Announces Completion of Phase 1 Hepatic Impairment Study with FASN Inhibitor Denifanstat | 129 | GlobeNewswire (Europe) | SAN MATEO, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors... ► Artikel lesen | |
| 25.03. | Sagimet Biosciences Inc.: Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors | 1 | GlobeNewswire (USA) | ||
| 25.03. | Sagimet Biosciences Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 25.03. | Sagimet Biosciences Inc. - 10-K, Annual Report | - | SEC Filings | ||
| 25.03. | Sagimet Biosciences Inc. - 8-K, Current Report | - | SEC Filings | ||
| 25.03. | Sagimet Biosciences Inc.: Sagimet Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates | 183 | GlobeNewswire (Europe) | Reported positive topline data from the Phase 2b FASCINATE-2 trial; at week 52 denifanstat met both primary efficacy endpoints and demonstrated statistically significant reduction in fibrosis Presented... ► Artikel lesen | |
| 30.01. | Sagimet Biosciences Inc. - 8-K, Current Report | 9 | SEC Filings | ||
| 26.01. | Sagimet Biosciences Inc.: Sagimet Biosciences Announces Pricing of Public Offering of Series A Common Stock | 6 | GlobeNewswire (USA) | ||
| 24.01. | Sagimet Biosciences Inc. - S-1/A, General form for registration of securities | 2 | SEC Filings | ||
| 23.01. | Sagimet Biosciences Inc.: Sagimet Biosciences Announces Proposed Public Offering of Series A Common Stock | 1 | GlobeNewswire (USA) | ||
| 23.01. | Sagimet Biosciences Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| 22.01. | Sagimet Biosciences Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 22.01. | Sagimet Biosciences Inc.: Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH | 225 | GlobeNewswire (Europe) | Denifanstat achieved statistically significant results on primary and multiple secondary endpoints in a 52-week clinical trial of 168 NASH patients with stage 2 or 3 fibrosis Primary efficacy endpoints:... ► Artikel lesen | |
| 29.12.23 | Sagimet Biosciences Inc. - 8-K, Current Report | 1 | SEC Filings |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| TUI | 5.845 |
| GAMESTOP | 3.883 |
| NEL | 3.726 |
| NVIDIA | 3.714 |
| EVOTEC | 3.416 |
| BAYER | 2.613 |
| PLUG POWER | 2.195 |
| BYD | 1.948 |
| VOLKSWAGEN | 1.421 |
| DEUTSCHE LUFTHANSA | 1.318 |
| RHEINMETALL | 1.261 |
| SUPER MICRO COMPUTER | 1.187 |
| BIONTECH | 1.181 |
| DEUTSCHE TELEKOM | 1.176 |
| ALLIANZ | 1.123 |
| AIXTRON SE | 996 |
| DEUTSCHE BANK | 910 |
| SIEMENS ENERGY | 906 |
| COMMERZBANK | 862 |
| RWE | 858 |
| BASF | 841 |
| THYSSENKRUPP | 805 |
| TESLA | 782 |
| MERCEDES-BENZ | 735 |
| BARRICK GOLD | 692 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
